From The Editor | June 29, 2020

Philadelphia As A Cell & Gene Therapy Hub

Erin

By Erin Harris, Editor-In-Chief, Cell & Gene
Follow Me On Twitter @ErinHarris_1

Philadelphia Skyline

What You’re About to Watch:

Saul Behar, Senior Vice President, Advancement and Strategic Initiatives at University City Science Center explains why Philadelphia has a unique combination of factors in terms of the strength of its assets around academic institutions, healthcare institutions, and its rich pharma legacy. For more information, watch the entire detailed roundtable discussion.

Why It Matters:

Philadelphia continues its upward trajectory as it has experienced 210% increase in venture capital in the life sciences between 2013 and 2018 along with the first FDA approved gene therapy and the first approved cell therapy.